Invention Grant
US07960548B2 Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis
失效
角质形成细胞生长因子受体 - 酪氨酸特异性抑制剂用于预防癌症转移
- Patent Title: Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis
- Patent Title (中): 角质形成细胞生长因子受体 - 酪氨酸特异性抑制剂用于预防癌症转移
-
Application No.: US11414890Application Date: 2006-05-01
-
Publication No.: US07960548B2Publication Date: 2011-06-14
- Inventor: J. Thomas Pento , Pui-Kai Li , Robert W. Brueggemeier , John C. Hackett
- Applicant: J. Thomas Pento , Pui-Kai Li , Robert W. Brueggemeier , John C. Hackett
- Applicant Address: US OH Columbus US OK Norman
- Assignee: The Ohio State University Research Foundation,The Board of Regents of the University of Oklahoma
- Current Assignee: The Ohio State University Research Foundation,The Board of Regents of the University of Oklahoma
- Current Assignee Address: US OH Columbus US OK Norman
- Agency: Calfee, Halter & Griswold LLP
- Main IPC: C07D471/02
- IPC: C07D471/02 ; C07D215/22 ; C07D215/227
Abstract:
Compounds and methods for treating, inhibiting, or delaying the onset of cancer in a subject by administering a therapeutically effective amount of a keratinocyte growth factor receptor tyrosine kinase (KGFR TK) inhibitor to the subject in need of such treatment. Also provided are compounds and methods for the treating, inhibiting, or delaying the onset of metastasis in a subject with cancer by administering a therapeutically effective amount of a KGFR TK inhibitor to the subject in need of such treatment.
Public/Granted literature
- US20070078176A1 Keratinocyte growth factor receptor-tyrosine specific inhibitors for the prevention of cancer metastatis Public/Granted day:2007-04-05
Information query
